vs

Side-by-side financial comparison of Genie Energy Ltd. (GNE) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $138.3M, roughly 1.1× Genie Energy Ltd.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 4.9%, a 66.3% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 23.6%).

Genie Energy Ltd. is an American energy company headquartered in Newark, New Jersey. It is a holding company comprising Genie Retail Energy, Genie Retail Energy International, Genie Energy Services, and Genie Energy Oil and Gas. Michael Stein is the Chief Executive Officer, Genie Energy Ltd.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

GNE vs STOK — Head-to-Head

Bigger by revenue
STOK
STOK
1.1× larger
STOK
$158.6M
$138.3M
GNE
Growing faster (revenue YoY)
STOK
STOK
+3637.5% gap
STOK
3661.1%
23.6%
GNE
Higher net margin
STOK
STOK
66.3% more per $
STOK
71.2%
4.9%
GNE

Income Statement — Q3 FY2025 vs Q1 FY2025

Metric
GNE
GNE
STOK
STOK
Revenue
$138.3M
$158.6M
Net Profit
$6.7M
$112.9M
Gross Margin
21.7%
Operating Margin
5.0%
70.2%
Net Margin
4.9%
71.2%
Revenue YoY
23.6%
3661.1%
Net Profit YoY
-33.9%
528.0%
EPS (diluted)
$0.26
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNE
GNE
STOK
STOK
Q3 25
$138.3M
Q2 25
$105.3M
Q1 25
$136.8M
$158.6M
Q4 24
$102.9M
$22.6M
Q3 24
$111.9M
Q2 24
$90.7M
Q1 24
$119.7M
Q4 23
$104.9M
Net Profit
GNE
GNE
STOK
STOK
Q3 25
$6.7M
Q2 25
$2.8M
Q1 25
$10.3M
$112.9M
Q4 24
$-15.3M
$-10.5M
Q3 24
$10.2M
Q2 24
$9.6M
Q1 24
$8.1M
Q4 23
$-24.5M
Gross Margin
GNE
GNE
STOK
STOK
Q3 25
21.7%
Q2 25
22.3%
Q1 25
27.3%
Q4 24
32.5%
Q3 24
33.9%
Q2 24
36.8%
Q1 24
28.2%
Q4 23
32.0%
Operating Margin
GNE
GNE
STOK
STOK
Q3 25
5.0%
Q2 25
1.9%
Q1 25
9.4%
70.2%
Q4 24
-20.2%
-60.4%
Q3 24
10.4%
Q2 24
11.6%
Q1 24
8.2%
Q4 23
-32.6%
Net Margin
GNE
GNE
STOK
STOK
Q3 25
4.9%
Q2 25
2.7%
Q1 25
7.5%
71.2%
Q4 24
-14.9%
-46.4%
Q3 24
9.1%
Q2 24
10.6%
Q1 24
6.8%
Q4 23
-23.4%
EPS (diluted)
GNE
GNE
STOK
STOK
Q3 25
$0.26
Q2 25
$0.11
Q1 25
$0.40
$1.90
Q4 24
$-0.58
$-0.15
Q3 24
$0.38
Q2 24
$0.36
Q1 24
$0.30
Q4 23
$-0.90

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNE
GNE
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$109.8M
$274.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.8M
$350.1M
Total Assets
$394.1M
$406.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNE
GNE
STOK
STOK
Q3 25
$109.8M
Q2 25
$106.0M
Q1 25
$118.3M
$274.8M
Q4 24
$110.1M
$128.0M
Q3 24
$141.8M
Q2 24
$126.8M
Q1 24
$106.9M
Q4 23
$111.4M
Stockholders' Equity
GNE
GNE
STOK
STOK
Q3 25
$198.8M
Q2 25
$197.0M
Q1 25
$198.0M
$350.1M
Q4 24
$190.5M
$229.0M
Q3 24
$211.1M
Q2 24
$202.1M
Q1 24
$192.9M
Q4 23
$197.2M
Total Assets
GNE
GNE
STOK
STOK
Q3 25
$394.1M
Q2 25
$383.1M
Q1 25
$384.4M
$406.9M
Q4 24
$371.3M
$271.6M
Q3 24
$341.7M
Q2 24
$322.8M
Q1 24
$328.3M
Q4 23
$330.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNE
GNE
STOK
STOK
Operating Cash FlowLast quarter
$13.9M
$131.8M
Free Cash FlowOCF − Capex
$131.7M
FCF MarginFCF / Revenue
83.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
2.07×
1.17×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNE
GNE
STOK
STOK
Q3 25
$13.9M
Q2 25
$1.1M
Q1 25
$15.3M
$131.8M
Q4 24
$13.0M
$-23.2M
Q3 24
$24.4M
Q2 24
$20.4M
Q1 24
$12.9M
Q4 23
$10.5M
Free Cash Flow
GNE
GNE
STOK
STOK
Q3 25
Q2 25
Q1 25
$13.6M
$131.7M
Q4 24
$-23.2M
Q3 24
$21.9M
Q2 24
$20.1M
Q1 24
$11.7M
Q4 23
FCF Margin
GNE
GNE
STOK
STOK
Q3 25
Q2 25
Q1 25
9.9%
83.0%
Q4 24
-102.7%
Q3 24
19.6%
Q2 24
22.1%
Q1 24
9.8%
Q4 23
Capex Intensity
GNE
GNE
STOK
STOK
Q3 25
Q2 25
Q1 25
1.3%
0.1%
Q4 24
0.2%
Q3 24
2.2%
Q2 24
0.4%
Q1 24
1.0%
Q4 23
Cash Conversion
GNE
GNE
STOK
STOK
Q3 25
2.07×
Q2 25
0.40×
Q1 25
1.49×
1.17×
Q4 24
Q3 24
2.39×
Q2 24
2.12×
Q1 24
1.59×
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GNE
GNE

Sales Channel Directly To Consumer$108.8M79%
Sales Channel Through Intermediary$23.5M17%
Genie Renewables GREW$6.0M4%

STOK
STOK

Segment breakdown not available.

Related Comparisons